Searched for
STRIDES PHARMA UNIT
Stocks in news: Waaree Energies, Kotak Bank, HDFC Bank, Strides Pharma, Persistent SystemsIndian markets showed volatility, ending nearly flat despite positive signals. Analysts note Nifty faces resistance from key moving average...- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Strides Pharma's Chestnut Ridge unit in New York classified as voluntary action indicated by USFDAStrides Pharma Science announced its US subsidiary, Strides Pharma Inc, has received a Voluntary Action Indicated classification from the U...
- OneSource in talks to raise Rs 1,670 crore in pre-listing roundOneSource, a TPG Growth-backed specialty pharma CDMO, is in talks with investors to raise $200 million. The company, formerly Stelis Biopha...
- Strides Pharma arm receives USFDA nod for potassium chloride oral solutionStrides Pharma Global, Singapore, has received approval for Potassium Chloride for Oral Solution USP, 20 mEq from the United States Food an...
- Strides Pharma receives USFDA approval for Prednisone tabletsStrides Pharma Global Pte Limited, Singapore, has received approval for Prednisone tablets USP in the strengths of 10 mg and 20 mg from the...
- Strides Pharma Science arm gets USFDA nod for HIV treatment drugDrug firm Strides Pharma Science on Friday said its step-down wholly-owned subsidiary, Strides Pharma Global, has received approval from th...
- Strides gets USFDA nod for generic Oxybutynin Chloride tabletsCompany's step-down wholly owned subsidiary Strides Pharma Global Pte Ltd, Singapore, has received approval for Oxybutynin Chloride Tablets...
- Strides receives USFDA approval for Ethacrynic Acid TabletsStrides Pharma Science announced that its step-down wholly-owned subsidiary, Strides Pharma Global Pte. Ltd, Singapore, has received approv...
- Strides Pharma Science arm gets USFDA nod for tension headache tabletsStrides Pharma Global Pte Ltd, Singapore, has received approval for Butalbital, Acetaminophen, and Caffeine tablets USP in the strengths of...
- Strides Pharma gets USFDA nod for Ursodiol tablets, a liver disease treatment drugStrides Pharma Science gets an approval from the USFDA to market Ursodiol tablets used for treating primary biliary cirrhosis, a progressiv...
- Strides Pharma gets USFDA nod to market generic headache drugThe product, which will be marketed by Singapore-based Strides Pharma Inc in the US market, is a generic version of Teva's Fioricet with Co...
- Strides receives USFDA approval for Flucytosine CapsulesThe product is a generic version of Ancobon Capsules, 250 mg and 500 mg, of Bausch Health US, LLC, the Bengaluru- headquartered pharmaceuti...
- Strides arm receives EIR for its US facilityThe facility is one of the very few manufacturing facilities in the US with a soft gel capsule (SGC) manufacturing suite for formulations w...
- Strides Pharma gets tentative nod from USFDA for pain relieving drugStrides Pharma Global Pte Ltd, Singapore, has received tentative approval for Diclofenac Potassium Softgel Capsules, 25 mg from the United ...
- Strides Pharma Science arm gets USFDA nod for drug to treat overactive bladderThe approved product is a generic version of Vesicare tablets of Astellas Pharma US, Inc.
- Strides arm and its partner get USFDA nod for hypokalemia treatment drugThe approved product, used in treatment of patients with hypokalemia, is a generic version of Merck, Inc's Potassium Chloride extended-rele...
- Strides gets USFDA nod to market laxative drug in USThe product will be manufactured at Strides' facility in Bengaluru and will be marketed by Strides Pharma in the US market.
- Strides Arcolab may fetch Rs 1250 cr from sale of domestic unitsStrides has received offers from a variety of global generic drug manufacturers as well as some Indian drug-makers and PE funds for the bus...
- Strides eyes M&As for speciality pharma, R&DI-bankers, acting on behalf of Strides, have signalled M&A interest on part of the promoter group for its speciality pharma and R&D units.
Load More
